ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 141 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $633,000 | +60.3% | 33,575 | 0.0% | 0.36% | +58.4% |
| Q2 2019 | $395,000 | -13.8% | 33,575 | 0.0% | 0.23% | -16.9% |
| Q1 2019 | $458,000 | +33.1% | 33,575 | 0.0% | 0.27% | +17.2% |
| Q4 2018 | $344,000 | -38.5% | 33,575 | 0.0% | 0.23% | -29.5% |
| Q3 2018 | $559,000 | +5.5% | 33,575 | 0.0% | 0.33% | -3.5% |
| Q2 2018 | $530,000 | +24.4% | 33,575 | 0.0% | 0.34% | +23.1% |
| Q1 2018 | $426,000 | +10.9% | 33,575 | 0.0% | 0.28% | +13.1% |
| Q4 2017 | $384,000 | -6.6% | 33,575 | 0.0% | 0.24% | -13.7% |
| Q3 2017 | $411,000 | +7.0% | 33,575 | 0.0% | 0.28% | +2.9% |
| Q2 2017 | $384,000 | -45.0% | 33,575 | 0.0% | 0.28% | -46.7% |
| Q1 2017 | $698,000 | 0.0% | 33,575 | 0.0% | 0.52% | -4.4% |
| Q4 2016 | $698,000 | -36.5% | 33,575 | 0.0% | 0.54% | -38.3% |
| Q3 2016 | $1,100,000 | +31.3% | 33,575 | 0.0% | 0.88% | +30.3% |
| Q2 2016 | $838,000 | +1.9% | 33,575 | 0.0% | 0.67% | -2.9% |
| Q1 2016 | $822,000 | -25.9% | 33,575 | 0.0% | 0.69% | -25.7% |
| Q4 2015 | $1,109,000 | +0.9% | 33,575 | 0.0% | 0.93% | -4.1% |
| Q3 2015 | $1,099,000 | – | 33,575 | – | 0.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
| Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
| PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
| Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
| Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
| PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
| Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
| Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |